Report
See how we champion diversity and inclusion in our workplace, the legal industry and the communities we serve.
Deals & Cases
Osler advised Fusion Pharmaceuticals in its US$2.4-billion proposed acquisition by AstraZeneca.
IN THE NEWS
New partner returns to Osler’s Litigation group.
New partner joins Osler’s Regulatory, Indigenous and Environmental group.
AWARDS & RECOGNITION
Osler has been recognized as one of Canada’s Best Diversity Employers (2024).
Let us help you stay up to date. Receive updates by email.
Subscribe Now
Recent Resources
Recent Press Articles
Recent Deals & Cases
Fusion Pharmaceuticals in its acquisition by AstraZeneca
Significant decision at the Supreme Court of Canada: five judge majority finds the Impact Assessment Act unconstitutional
SK On in connection with an $1.2 billion investment with Ford and EcoPro BM in the Province of Québec